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Abstract
Over 300 blood group antigens have been discovered in different parts of the world and most them are classified
into 35 systems. India has contributed a few rare blood groups including the Bombay phenotype, Indian blood
group antigens like In(a), In5 and I-i- phenotype. Besides, there are a few other rare blood groups, though not
discovered in India, were encountered here including a host of the weaker variants of A, B and H antigens, the
ultra-rare Mg antigen of the MNS blood groups, phenotypes like D- -, Rh-null, I-int, In(b-), Colton-null and
r(y).
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Over 300 human blood group antigens have been
recognized and classified into 35 systems. Each
system has its own antigen make-up. Many of these
antigens were discovered over a period in different
parts of the World, mainly in the West. Steve Pierce
and Marion Reid has compiled a historical account
and lucidly presented it in form of a book.1 India
has also made its contribution in the field of blood
groups with a few of the original discoveries as
outlined here.
“Bombay” phenotype
The “Bombay” blood group was discovered in
December 1951. A patient, who had met with a
railway accident, was grouped as O but none of the
115 group O donors were found matching due to
the presence of a particular antibody. The following
month, another patient with stab-wound injury,
presented compatibility problem with group O
donors. However, both these patients were mutually
compatible. Later, a deliberate search yielded one
more donor with identical characteristics. These
blood samples were referred to BGRU, London for
further work up, where it was declared to be a “new”
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blood group2 and was later named as “Bombay”
phenotype. While ordinary group O persons have
a high frequency antigen (HFA) H present on their
RBCs, individuals with “Bombay” phenotype lack H
antigen on their RBCs, hence the phenotype is also
denoted as Oh. A person with Oh phenotype has
naturally occurring anti-H akin to antibodies of the
ABO blood groups.
In a systematic search, 3 out of 42,297 samples
screened were found to be Oh phenotype suggesting
to its frequency as 1:13000 in the general population
in Mumbai.3 Further screening, based on increased
sample size from two major hospitals, viz., KEM
and J J hospitals in Mumbai, overall incidence was
improved to 1:7600 with 22 cases among the 1,67,404
samples screened. Half of the cases belonged to the
south-west of Maharashtra, in particular to the
regions of Konkan and Goa.4 In view of this, in a
survey made in 400 villages from this region, an
incidence of Oh phenotype in this region was worked
out to be 1:4000 (six cases among 24,085 individuals
screened)5 that gained support from previous
observation. The cases were referred from most
states of India in varied numbers but the majority
was from western and southern Indian states. By
the year 1988, a total of 179 cases were recorded
with state-wise distribution as Maharashtra (122),
Karnataka (15), AP (8), Goa (6), Gujarat (5) to name
a few.6
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The discovery of the “Bombay” phenotype had well
explained the basics of the biosynthesis of the ABO
blood group antigens.
I-i- Phenotype
The I blood group system is characterized as a
developmental antigen, i.e., I antigen is weakly
expressed on the fetal RBCs and gradually
strengthen over a period of 18 months to reach
a peak to remain stable through the adult life. An
antigen showing a reciprocal character to I was
termed as i, and is strongly expressed on the RBCs
from newborns and weakens gradually through this
period and remains weak in adult life.7 Some rare
adults with the I-i antigens strength similar to that
of the newborns are under genetic influence and
considered homozygote for the I negative status so
were termed as adult-ii, the heterozygote members
in the family shows an intermediate reaction pattern
for the Ii antigens and are classified as I-int.
We had encountered healthy blood donors with
depressed I antigen on RBCs to the level of newborns
without any concomitant rise of the i antigen. We
termed this phenotype as I-i-.8 It was found with a
frequency of 1:900. The family study among the
three propositi showed no other members having
this phenotype. However, in a larger family, three
more members with I-i- phenotype were noticed.
One family, with 95 members, had as many as 15 I-imembers and six others with a partial suppression
of the I antigen.9 While the phenotype was found
to be familial in character, its inheritance did not
apparently follow the Mendelian law of inheritance
presumably due to the complexity in interaction
of the other blood groups including the ABH at
biosynthetic level. Interestingly, all the individuals
with this phenotype belonged to A1 or A1B and the
A1 antigen strength on their RBCs was significantly
higher when compared to those with normal
complements of I-i antigens thereby suggesting the
association between the ABO and the I blood groups
at precursor level.
Indian antigens
Ina
In the year 1970, an immune serum with antiRh.D was referred by the diagnostic firm for QC.
34
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Although, the serum showed a presence of potent
anti-D, it reacted with certain D-neg RBCs as well.
An additional antibody, isolated by absorptionelution methods, was found to be reacting with the
RBCs of about 2-3% of the random blood samples.
After preliminary work up, the same absorbed
serum was referred to the Blood Group Reference
Laboratory, London for further investigations.
Initial reports showed no reactivity against the
panel of red cells tested. Second consignment, of
the serum along with the reacting red cells, was
sent for reinvestigation. Then it was reported that
the serum did have reactivity against the antigen on
red cells that was provided but the same was absent
on their red cell panel. The antibody was confirmed
as a hitherto unknown antigen and was named after
India, and being the first of its kind, was termed as
In(a).10
The significance of this discovery was soon realized
when about 30 commercial anti-D reagents produced
in India were tested and found to have anti-In(a).
The reason for this was that several Rh.D-(Rh
subtype rr, cde/cde) voluntary paid donors (VPDs)
were immunized for the production of anti-D using
RBCs of one VPD named IS (Rh subtype Ror, cDe/
cde) who incidentally possessed the antigen to be
discovered later as Ina. While such anti-D reagents
were in use, about 3-5% of the Rh.D- bloods might
have been falsely entered as Rh.D+.
Discovery of In(a) paved way to identify its
antithetical antibody, called Salis, to a high frequency
antigen (HFA) detected earlier. The Salis antibody
was rechristened as anti-In(b).11 The Indian system
was expanded when two other antigens, INFI (In3)
and INJA (In4) were recognized in the year 2007.12
In5 (INRA)
The Indian blood group system was further
expanded when an antibody to an HFA was found
during the routine pre-transfusion compatibility
tests. Preliminary investigations indicated to its
specificity within the Indian system, though its
specificity to In(b) as an HFA was ruled out as the
RBCs reacted with two examples of anti-In(b). The
blood specimen was referred to IBGRL, Bristol, UK
to rule-out or rule-in the specificity to the other two
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known HFA of the Indian system, viz., In3 and In4.
The patient’s RBCs were typed positive for In3 and
In4 thus ruling out these specificities. The RBCs
were typed positive for the host of HFAs like Kna,
McCa, Yta, U, Vel, Ena, Kpb, Jsb, Wrb, Ge and CD99
excluding its specificities to these antigens. The
patient’s antibody reacted with RBCs of rare bloods
like In(b-), In:-3, In:-4, Gerbichnull, Rhnull, D- -/D- -,
MkMk, Fy(a-b-), Gy(a-), and K0, further ruling out its
specificity to these antigens. The findings indicated
to its serological specificity against a hitherto
unknown antigen.
A striking observation was its weak reactivity with
the RBCs from Lu(a-b-(InLu). CD44 (IN) antigens
were known for their suppression on RBCs from
Lu(a-b-(InLu) phenotype.13 Hence, the molecular
typing on exons of the haemopoeitic isoform of the
CD44 (IN) gene was ensued. The result showed a
novel homozygous missense mutation c.449G>A in
exon 5 of CD44 encoding p.Arg150His amino acid
substitution at the protein level that explained the
lack of a novel HFA.14 We coined its name as INRA,
taking the first two letters from the name of the
blood group system and the last two letters from the
patient’s name as per convention. ISBT recognized
the INRA as a new antigen of Indian blood groups
and assigned the numerical term as In5.
Other novel features found in the Indian
Population
Apart from these, India has discovered the anti-H
Kantola lectin Momardica dioica in an Indian plant,15
Citrate dependent anti-H,16 Streptomycin antibiotic
dependent
panagglutination,17
Bicarbonate
18
anion dependent ant-”N”, and spontaneous cold
agglytination (SpCA) phenomenon.19 Besides,
there are also several rare phenotypes, though not
discovered in India, have their presence in India.
These include a host of the weaker variant of A, B,
and H antigens,20 ultra-rare Mg antigen of the MNS
blood groups,21 phenotypes like D- -,22 Rh-null,23
I-int,24 In(b-),25 Colton-null26 and r(y).27
Conclusion
India has contributed towards the discoveries of a
few blood groups including the Bombay phenotype,
Indian blood groups, i.e., In(a), In5 and the I-iphenotype. Besides, there are a few other rare blood
groups, though not discovered in India, have been

encountered here including a host of the weaker
variants of A, B and H antigens, ultra-rare Mg
antigen, phenotypes like D- -, Rh-null, I-int, In(b), Colton-null and r(y). Of these, six phenotypes
are of transfusion significance, viz., Bombay (Oh),
D- -, Rh-null, In(b-),In5 and Colton-null. The
supply of these rare bloods for transfusion could
be a challenging task for the recipients who have
developed alloantibodies through transfusion and/
or pregnancies.
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